Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.62 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.62 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PYGL | P06737 | 5/20 | 0.48 |
| ▸ | PYGM | P11217 | 5/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4821648 | 0.92 | SIRT2 (0.63) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL2746237 | 0.91 | KDR (0.60) | SIRT2SIRT1SIRT3KDRFGFR1 | |
| SCHEMBL4821996 | 0.90 | SIRT2 (0.52) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL4822988 | 0.89 | SIRT2 (0.51) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL4812015 | 0.88 | KDR (0.60) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL4548758 | 0.83 | KDR (0.59) | SIRT2SIRT1SIRT3KDRFGFR1 | |
| SCHEMBL2747087 | 0.83 | SIRT2 (0.62) | SIRT2SIRT1SIRT3KDRFGFR1 | |
| SCHEMBL4548755 | 0.83 | KDR (0.58) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL4548767 | 0.82 | KDR (0.58) | SIRT2SIRT1SIRT3NPC1RAB9A | |
| SCHEMBL2749251 | 0.82 | KDR (0.70) | SIRT2SIRT1SIRT3KDRFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435823-B2 | Compounds and methods of use | AMGEN INC. (US) | 2008-10-14 | — | — | US | disclosed |
| US-20060241115-A1 | Compounds and methods of use | AMGEN INC. | 2006-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241115-A1 | Compounds and methods of use | HGF, HGFAC, MET | SIRT2 1966/4885SIRT1 1349/4885SIRT3 1430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.